You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Teladoc Health Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
Teladoc Health Company Info
Teladoc provides video-conferencing consultations for everyday customers with general medical professionals, dermatologists, and behavioral health specialists.
News & Analysis
These stocks are undervalued considering their long-term growth potential.
These stocks suffered in 2022. And they have reason to rebound.
The tech giant is making another attempt to get into the telehealth business, but this time it's taking a different approach.
These beaten-down innovators have industry-changing potential.
Innovative products and services could keep these companies growing.
The key to investing is to look at the long-term picture.
It's time to go bargain hunting.
The stock is heading for a 64% decline this year.
Plus, we take a look at how Airbnb does business.
Toymakers, tech stocks, and the ripple effects of slowing population growth.
These companies could see their sales soar as seniors increasingly choose to live in their homes longer.
Its ability to cut healthcare costs is only growing more compelling.
TDOC earnings call for the period ending September 30, 2022.
TDOC earnings call for the period ending June 30, 2022.
TDOC earnings call for the period ending March 31, 2022.
TDOC earnings call for the period ending December 31, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.